@FiercePharma: Pennsylvania appeals court affirms $45M in Prempro damages; Pfizer says it'll go to state supreme court. Report | Follow @FiercePharma
> Merck ($MRK) agreed to pay $5 million in attorneys' fees and tweak its corporate governance rules to settle a shareholder suit over the delayed Enhance trial results. Story
> Indian regulators fined a former Ranbaxy Laboratories director and his wife for insider trading in Orchid Chemicals & Pharmaceuticals in 2008. Report
> U.K. regulators will review Shire's ADHD remedy Venvanse, sold as Vyvanse in the U.S., which would be the first amphetamine-based drug for the disorder in the EU if approved. Article
> Using certain seizure drugs in combination with HIV fighters can cause the antivirals to fail or reduce the effectiveness of the epilepsy meds, a new study finds. Release
> Eye drug maker Ista Pharmaceuticals says it's looking for higher sales and profits in 2012, with revenue expected to hit $180 million to $195 million. News
> Insys Therapeutics won FDA approval for its cancer pain drug Subsys, a sublingual fentanyl spray. Release
> Almost 33% of U.K. patients don't fill their prescriptions, saying they didn't have time or didn't want to pay for it. Story
> Rodman & Renshaw started covering Amylin ($AMLN) stock with an "underperform" rating and an $8 price target. Item
Biotech News
@FierceBiotech: Bleak forecast puts Lilly's R&D game plan to the test. Will this change Lechleiter's approach? Article | Follow @FierceBiotech
@JohnCFierce: Germany's Apogenix raises 7.5ME for glioblastoma drug work. Release | Follow @JohnCFierce
@RyanMFierce: Here's my own take on @Quintiles new digital patient unit, with insights from the group's chief: Story | Follow @RyanMFierce
@FierceMedDev: FDA Orders Safety Evaluation of Vaginal Mesh--Bloomberg. Article | Follow @FierceMedDev
> Fast-growing Forma grabs $815M cancer discovery deal with Boehringer. News
> Bleak forecast puts Eli Lilly's ambitious R&D game plan to the test. More
> Merck spinout nails promising study on hep C vaccine. Story
Manufacturing News
> Novartis adds OTC drug plant to GMP fix list. News
> AZ starts work on record-setting plant in China. Item
> Report: Big Pharma finds Indian collaborations costly. Story
> Pharma fires, pollution targeted in India. More
> Hospira enters angry-investor phase of remediation. Article
> Expired-drug take vs. toss debate gets new vetting. Story
Vaccine News
> Study: Most girls who get HPV vax say they see need to practice safe sex. Item
> FDA approves Pfizer's Prevnar 13 for adults over 50. Article
> Argentina fines GSK $93K for Synflorix vaccine trial in which 14 babies died. News
And Finally... Missed some FDA guidance last year? in-Pharma Technologist rounds up 2011's documents. Report